MedPath

A Trial of the effect of tolvaptan on patients with nephrotic state and chronic heart failure

Not Applicable
Conditions
nephrotic syndrome with heart failure
Registration Number
JPRN-UMIN000011763
Lead Sponsor
Shonan Kamakura General Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
20
Inclusion Criteria

Not provided

Exclusion Criteria

1. who have the history of the allergy to this drug or related compounds 2. anuria (<100ml/day) 3. who do not feel thirst or who have difficulty in drinking 4. serum Na >145mEq/l 5. women who are pregnant or have the possibility of pregnancy

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath